Report on the ‘Accurate Results for Patient Care Workshop 2017’



A ‘full house’ of 117 delegates from 27 countries attended the biennial meeting of the Joint Committee for Traceability in Laboratory Medicine (JCTLM), which was held on 4/5 December 2017 at the Bureau International des Poids et Mesures (BIPM) in Sèvres, near Paris.

The two-day programme for the meeting included presentations and informed discussion on:

  • Why traceability matters to patients
  • Traceability in external quality assessment
  • Traceability and the IVD industry: the manufacturers role
  • Traceability in the investigation of infectious diseases
  • Traceability: a global perspective
  • JCTLM update

The final element of the programme focussed on the clinical challenge of neurodegenerative disease with contributions on the requirements for and development of high quality biomarker assays for the investigation of Alzheimer’s disease, Parkinson’s disease and other debilitating conditions.

These presentations will shortly be available on an open access basis – this news will follow.

There is growing recognition of the importance of metrological traceability as a driver for accurate results for patient care through facilitating reduced between-method variability in laboratory medicine. Medical researchers; national metrology institutes; the manufacturers of in-vitro diagnostic systems; and laboratory medicine specialists are equal partners in delivering improved clinical laboratory methods and all were well represented at this workshop.

Further information about JCTLM and access to the presentations may be found at


Back to news